Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Pharma to Spend $73.5 Million on Global Technology Incubator

publication date: Jul 11, 2017
Fosun Pharma will invest $73.5 million over nine years in an innovative technology incubator. The incubator will search worldwide for innovative projects, which Fosun said will help meet its stategic innovative and global goals. Professor Tian Xu, deputy head of Genetics at Yale University and Chief Science Advisor to Fosun, will serve as the chairman of the incubator’s academic committee. The Fosun incubator will seek innovative technologies in pharmaceuticals, regenerative medicine and artificial intelligence. More details....

Stock Symbols: (SHA: 600196; HK: 2196)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital